TheraRadar
← Back
Data updated: Mar 29, 2026

SPECGX LLC

ImmunologyMetabolicNeurology
Pharma

SPECGX LLC is a pharmaceutical company focused on Immunology, Metabolic, Neurology.

1973
Since
49
Drugs
-
Trials
954
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 60%
3 drugs
Metabolic 20%
1 drugs
Neurology 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...